Page last updated: 2024-11-06

1,2-benzisoxazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,2-Benzisoxazole is a heterocyclic aromatic compound that is used as a building block for various pharmaceuticals and agrochemicals. It is synthesized through various methods, including the condensation of o-nitrobenzaldehyde with hydroxylamine. 1,2-Benzisoxazoles have been investigated for their potential pharmacological effects, including anti-inflammatory, antibacterial, and antifungal activities. Notably, they are often found in molecules that act as inhibitors of various enzymes and receptors, playing a role in the development of drugs for conditions such as cancer and Alzheimer's disease. The versatility of 1,2-benzisoxazole as a synthetic scaffold, coupled with its promising biological activity, makes it a subject of ongoing research.'

1,2-benzisoxazole: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1,2-benzoxazole : A benzoxazole in which the benzene ring is fused to a 1,2-oxazole ring across positions 4 and 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

benzisoxazole : Compounds based on a fused 1,2-oxazole and benzene bicyclic ring skeleton. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID71073
CHEMBL ID314871
CHEBI ID51554
SCHEMBL ID8438
SCHEMBL ID2213595
MeSH IDM0407662

Synonyms (38)

Synonym
benzo[d]isoxazole
CHEMBL314871
CHEBI:51554 ,
benz(d)isoxazole
271-95-4
4,5-benzisoxazole
benzisoxazole
1-oxa-2-aza-1h-indene
1,2-benzoxazole
indoxazene
inchi=1/c7h5no/c1-2-4-7-6(3-1)5-8-9-7/h1-5
1,2-benzisoxazole
1,2-benzisoxazole, >=95.0%
B0969
isoindoxazine
AKOS001302541
A818951
0r1 ,
einecs 205-983-1
d879rkm5nq ,
unii-d879rkm5nq
FT-0627231
SCHEMBL8438
SCHEMBL2213595
4,5-benzisoazole
1-oxa-2-azaindene
DTXSID20181567
mfcd00005852
J-016689
1,2-benzoisoxazole
CCG-321128
Q791818
STL570242
trifluoromethylphosphonicacid
CS-0155959
EN300-25961
SY049298
Z220335556
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
1,2-benzoxazolesCompounds based on a fused 1,2-oxazole and benzene bicyclic ring skeleton, with the O atom positioned adjacent to one of the positions of ring fusion.
mancude organic heterobicyclic parent
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID728444Binding affinity to Enterobacteria phage T4 lysozyme L99A/M102H double mutant expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 1 mM at pH 5.4 by circular dichroism analysis2013Journal of medicinal chemistry, Apr-11, Volume: 56, Issue:7
The impact of introducing a histidine into an apolar cavity site on docking and ligand recognition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (13.33)29.6817
2010's13 (86.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.44 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (13.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (86.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]